Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$972M |
| 2 |
Meta Platforms (Facebook)
META
|
+$324M |
| 3 |
Webster Financial
WBS
|
+$279M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Advanced Micro Devices
AMD
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
STL
Sterling Bancorp
STL
|
+$283M |
| 4 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$252M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.89% |
| 2 | Technology | 16.14% |
| 3 | Industrials | 12.35% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
First US Bancshares
FUSB
$93M
| $346K | ﹤0.01% |
29,781
+313
| +1% | +$3.42K |
|
3227
Fulgent Genetics
FLGT
$574M
| $345K | ﹤0.01% |
5,527
| – | – |
|
|
TCRR
3228
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $342K | ﹤0.01% |
123,951
-2,585
| -2% | -$8.13K |
|
|
TOUR
3229
Tuniu
TOUR
$54.2M
| $340K | ﹤0.01% |
38,153
| – | – |
|
3230
StoneCo
STNE
$2.78B
| $339K | ﹤0.01% |
29,004
+3,647
| +14% | +$47.7K |
|
3231
Live Ventures
LIVE
$29.6M
| $336K | ﹤0.01% |
7,898
+1,476
| +23% | +$48.1K |
|
|
FFBW
3232
DELISTED
FFBW, Inc. Common Stock
FFBW
| $326K | ﹤0.01% |
27,016
| – | – |
|
3233
Pathfinder Bancorp
PBHC
$102M
| $324K | ﹤0.01% |
15,182
| – | – |
|
|
SRGA
3234
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $324K | ﹤0.01% |
35,463
-40,213
| -53% | -$611K |
|
3235
CKX Lands
CKX
$22.2M
| $322K | ﹤0.01% |
29,485
| – | – |
|
|
APTX
3236
DELISTED
Aptinyx Inc. Common Stock
APTX
| $320K | ﹤0.01% |
140,711
+16,774
| +14% | +$50.3K |
|
3237
Alpha Pro Tech
APT
$50.7M
| $319K | ﹤0.01% |
75,903
| – | – |
|
3238
GoodRx Holdings
GDRX
$1.07B
| $319K | ﹤0.01% |
+16,537
| New | +$379K |
|
3239
Bank7 Corp
BSVN
$476M
| $318K | ﹤0.01% |
13,445
+4,492
| +50% | +$108K |
|
|
ONEM
3240
DELISTED
1Life Healthcare
ONEM
| $316K | ﹤0.01% |
28,487
-4,269
| -13% | -$47.8K |
|
3241
J.W. Mays
MAYS
$78.6M
| $315K | ﹤0.01% |
8,193
| – | – |
|
3242
Socket Mobile
SCKT
$3.67M
| $310K | ﹤0.01% |
77,354
-2,118
| -3% | -$8.15K |
|
|
CBIO
3243
Crescent Biopharma
CBIO
$555M
| $309K | ﹤0.01% |
2,711
-2,933
| -52% | -$344K |
|
3244
Veracyte
VCYT
$4.77B
| $309K | ﹤0.01% |
11,202
-175
| -2% | -$5K |
|
|
PFIN
3245
DELISTED
P&F Industries
PFIN
| $306K | ﹤0.01% |
50,884
+10
| +0% | +$61 |
|
3246
Hayward Holdings
HAYW
$3.26B
| $304K | ﹤0.01% |
+18,284
| New | +$346K |
|
3247
Driven Brands
DRVN
$2.37B
| $303K | ﹤0.01% |
+11,521
| New | +$334K |
|
|
CARV
3248
DELISTED
Carver Bancorp
CARV
| $302K | ﹤0.01% |
43,072
| – | – |
|
3249
Petco
WOOF
$794M
| $302K | ﹤0.01% |
15,432
+5,036
| +48% | +$94.2K |
|
3250
Foghorn Therapeutics
FHTX
$278M
| $300K | ﹤0.01% |
+19,758
| New | +$271K |
|
Similar funds
Dimensional Fund Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Dimensional Fund Advisors held 3,635 positions worth $325B, down 1.9% from $331B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2022 filing shows 98 new, 2,062 increased, 1,167 reduced and 121 closed positions. Its largest new stake was Shell: 18,315,111 shares worth $1.01B. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $780M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2022 buy was Shell: 18,315,111 shares worth $1.01B.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q1 2022, an estimated $324M increase.
- Dimensional Fund Advisors's biggest Q1 2022 reduction was Canadian Pacific Kansas City, cutting an estimated $241M.
- Dimensional Fund Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $780M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $325B portfolio in Q1 2022.
- Dimensional Fund Advisors opened 98 new positions and closed 121 in Q1 2022.
- Dimensional Fund Advisors's portfolio value fell 1.9% quarter-over-quarter to $325B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.